AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20880343 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine plus ≤3 mealtime lispro (G+L)
Number of subjects: 484
Study 20880343 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 484
Study 18035140 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (0.025 U/kg/hr) on days 1 to 7 with 20% dextrose to maintain normoglycemia
Number of subjects: 16
Study 18035140 — intervention group
Group type: COMPARATOR
Intervention: Standard neonatal care
Number of subjects: 16
Study 16173851 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-focused group intervention (6 sessions)
Number of subjects: 238
Study 16173851 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-focused group intervention
Number of subjects: 238
Study 16173851 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study 12753317 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene hydrochloride, 60 mg/day
Number of subjects: 50
Study 12753317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11421376 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole 20 mg/kg with cimetidine 10 mg/kg twice daily
Number of subjects: 6
Study 11421376 — intervention group
Group type: COMPARATOR
Intervention: Albendazole 5 mg/kg
Number of subjects: 6
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg IK-HIR02 (IV)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg IK-HIR02 (IV)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg IK-HIR02 (IV)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg IK-HIR02 (SC)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg IK-HIR02 (SC)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg IK-HIR02 (SC)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg IK-HIR02 (SC, b.i.d.)
Number of subjects: 18
Study 8872129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin (0.7 micrograms/ml) as anticoagulant
Number of subjects: 18
Study 1900575 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine (100 micrograms) and Methimazole (10 mg)
Number of subjects: 109
Study 1900575 — intervention group
Group type: COMPARATOR
Intervention: Placebo and Methimazole (10 mg)
Number of subjects: 109
Study 6823860 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (diuretic)
Number of subjects: 29
Study 6823860 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (centrally acting agent)
Number of subjects: 29
Study 29746446 — intervention group
Group type: EXPERIMENTAL
Intervention: Corner Pocket technique (20 mL local anesthetic injected primarily in the corner pocket)
Number of subjects: 36
Study 29746446 — intervention group
Group type: COMPARATOR
Intervention: Neural Cluster technique (20 mL local anesthetic injected primarily inside the neural cluster)
Number of subjects: 36
Study 29746446 — intervention group
Group type: EXPERIMENTAL
Intervention: Corner Pocket technique
Number of subjects: 36
Study 29746446 — intervention group
Group type: COMPARATOR
Intervention: Neural Cluster technique
Number of subjects: 36
Study 28514618 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training
Number of subjects: 160
Study 28514618 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 160
Study 28514618 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 160
Study 28514618 — intervention group
Group type: COMPARATOR
Intervention: All exercise groups
Number of subjects: 160
Study 26143238 — intervention group
Group type: EXPERIMENTAL
Intervention: Core decompression with concentrated bone marrow injection (Group A)
Number of subjects: 28
Study 26143238 — intervention group
Group type: COMPARATOR
Intervention: Core decompression without bone marrow injection (Group B)
Number of subjects: 28
Study 23978002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITNs)
Number of subjects: 0
Study 20452184 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium lactis, and Streptococcus thermophiles for 6 months
Number of subjects: 36
Study 20452184 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 36
Study 20452184 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsules for patients with baseline ammonia levels > 50 mmol/L
Number of subjects: 36
Study 17600650 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based feedback (WI)
Number of subjects: 124
Study 17600650 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based feedback plus motivational interviewing (MI)
Number of subjects: 124
Study 17600650 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study 17000789 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 60
Study 17000789 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (2 mcg x kg(‐1) x min(‐1))
Number of subjects: 60
Study 17000789 — intervention group
Group type: COMPARATOR
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 60
Study 14511455 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery enhanced learning (I-learning) using low-cost Virtual Reality technology for motor imagery.
Number of subjects: 0
Study 14511455 — intervention group
Group type: COMPARATOR
Intervention: Virtual training
Number of subjects: 0
Study 10782604 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry available to paramedics
Number of subjects: 0
Study 10782604 — intervention group
Group type: COMPARATOR
Intervention: No pulse oximetry available to paramedics
Number of subjects: 0
Study 8993489 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine (80, 120, or 160 mg/day)
Number of subjects: 460
Study 8993489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study 8993489 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine
Number of subjects: 460
Study 1614100 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac (Voltaren Ophtha)
Number of subjects: 37
Study 1614100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 6369584 — intervention group
Group type: EXPERIMENTAL
Intervention: Grassi test
Number of subjects: 48
Study 6369584 — intervention group
Group type: COMPARATOR
Intervention: No test (non-Grassi)
Number of subjects: 48
Study 29541824 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaundiced group
Number of subjects: 104
Study 29541824 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 27423583 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation
Number of subjects: 32
Study 27423583 — intervention group
Group type: COMPARATOR
Intervention: Soy protein (Control)
Number of subjects: 32
Study 24739766 — intervention group
Group type: EXPERIMENTAL
Intervention: Penn Resiliency Program (PRP)
Number of subjects: 58
Study 24739766 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 23768270 — intervention group
Group type: EXPERIMENTAL
Intervention: Core isometric endurance training (n=5)
Number of subjects: 10
Study 23768270 — intervention group
Group type: EXPERIMENTAL
Intervention: Core isotonic strength training (n=5)
Number of subjects: 10
Study 22432561 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10) (NPN 02176955)
Number of subjects: 21
Study 22432561 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10)‐P5P‐PC
Number of subjects: 21
Study 22432561 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ(10) (DIN 02231736)
Number of subjects: 21
Study 18189160 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC(75)
Number of subjects: 147
Study 18189160 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC(90)
Number of subjects: 147
Study 16670544 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically treated clubfoot
Number of subjects: 7
Study 11940136 — intervention group
Group type: EXPERIMENTAL
Intervention: BOMP index
Number of subjects: 43
Study 11940136 — intervention group
Group type: EXPERIMENTAL
Intervention: EIB index
Number of subjects: 43
Study 11940136 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental gingivitis (EG)
Number of subjects: 43
Study 11940136 — intervention group
Group type: COMPARATOR
Intervention: Floss (FL)
Number of subjects: 43
Study 10235108 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 1775
Study 10235108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1775
Study 7565975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-directed, multidisciplinary intervention
Number of subjects: 282
Study 7565975 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 282
Study 2251873 — intervention group
Group type: EXPERIMENTAL
Intervention: B subunit‐killed whole cell (BS‐WC)
Number of subjects: 53
Study 2251873 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed whole cell (WC)
Number of subjects: 53
Study 2251873 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli K12 strain (K12)
Number of subjects: 53
Study 2251873 — intervention group
Group type: EXPERIMENTAL
Intervention: BS-WC, WC, K12
Number of subjects: 53
Study 6103706 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 210
Study 6103706 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 210
Study 6103706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 6103706 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 210
Study 6103706 — intervention group
Group type: COMPARATOR
Intervention: Flunitrazepam 2 mg
Number of subjects: 210
Study 31583738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioimpedance Spectroscopy (BIS)
Number of subjects: 135
Study 31123915 — intervention group
Group type: EXPERIMENTAL
Intervention: EF-training condition (working memory, inhibition, cognitive flexibility training)
Number of subjects: 61
Study 31123915 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 61
Study 27793396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 75/150 mg every 2 weeks (Q2W)
Number of subjects: 4915
Study 27793396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg Q2W
Number of subjects: 4915
Study 27793396 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or ezetimibe)
Number of subjects: 4915
Study 25866250 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer Carbonate (SC)
Number of subjects: 24
Study 25866250 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate (LC)
Number of subjects: 24
Study 25866250 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer Hydrochloride (SH)
Number of subjects: 24
Study 25866250 — intervention group
Group type: COMPARATOR
Intervention: Proton Pump Inhibitor (PPI) therapy
Number of subjects: 24
Study 24463421 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐Health4Uth home safety intervention
Number of subjects: 1292
Study 22644174 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan (F) 2.5 mg
Number of subjects: 346
Study 22644174 — intervention group
Group type: COMPARATOR
Intervention: Comparators (Rizatriptan (R) 10 mg, Zolmitriptan (Z) 2.5 mg, Almotriptan (A) 12.5 mg)
Number of subjects: 346
Study 19765270 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch program (experimental group)
Number of subjects: 1323
Study 19765270 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1323
Study 17202903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness training at health clubs (n = 833)
Number of subjects: 6021
Study 17202903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient rehabilitation (n = 468)
Number of subjects: 6021
Study 17202903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary inpatient rehabilitation (n = 135)
Number of subjects: 6021
Study 17202903 — intervention group
Group type: COMPARATOR
Intervention: Usual insured individual care
Number of subjects: 6021
Study 15220940 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (single high dose every 4 months)
Number of subjects: 1405
Study 11144995 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA (adenosine receptor agonist)
Number of subjects: 13
Study 11144995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 11144995 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical antagonist
Number of subjects: 13
Study 10072743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation (smoking cessation intervention)
Number of subjects: 3
Study 10072743 — intervention group
Group type: COMPARATOR
Intervention: Control (non-intervention group)
Number of subjects: 3
Study 7602348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense therapy (cyclophosphamide 1,000 mg/m2 and cisplatin 100 mg/m2 intravenously every 3 weeks for four courses)
Number of subjects: 485
Study 7602348 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (cyclophosphamide 500 mg/m2 and cisplatin 50 mg/m2 intravenously every 3 weeks for eight courses)
Number of subjects: 485
Study 7602348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense therapy
Number of subjects: 485
Study 7602348 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 485
Study 2186769 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (1 mg daily minidose)
Number of subjects: 40
Study 2186769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 705564 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP (cyclophosphamide, vinblastine, procarbazine, prednisone)
Number of subjects: 191
Study 705564 — intervention group
Group type: EXPERIMENTAL
Intervention: CCVPP (CVPP + CCNU)
Number of subjects: 191
Study 705564 — intervention group
Group type: EXPERIMENTAL
Intervention: CCVPP
Number of subjects: 191
Study 705564 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP
Number of subjects: 191
Study 705564 — intervention group
Group type: COMPARATOR
Intervention: CCVPP vs CVPP
Number of subjects: 191
Study 30899994 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 2463
Study 30899994 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide
Number of subjects: 2463
Study 28780236 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase 0.4 mg/kg (max 40 mg)
Number of subjects: 1100
Study 28780236 — intervention group
Group type: COMPARATOR
Intervention: Alteplase 0.9 mg/kg (max 90 mg)
Number of subjects: 1100
Study 28780236 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Number of subjects: 1100
Study 28780236 — intervention group
Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 1100
Study 26606120 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal mesh
Number of subjects: 70
Study 26606120 — intervention group
Group type: COMPARATOR
Intervention: Sacrospinous ligament fixation
Number of subjects: 70
Study 23098630 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalens HD silicone accommodating IOL
Number of subjects: 0
Study 23098630 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetraflex acrylic accommodating IOL
Number of subjects: 0
Study 23098630 — intervention group
Group type: COMPARATOR
Intervention: Tecnis 1‐piece monofocal (nonaccommodating) control IOL
Number of subjects: 0
Study 22276413 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise prior to exposure (30 min on a cycle ergometer, including 20 min at moderate intensity)
Number of subjects: 48
Study 22276413 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise after exposure (30 min on a cycle ergometer, including 20 min at moderate intensity)
Number of subjects: 48
Study 22276413 — intervention group
Group type: COMPARATOR
Intervention: No-exercise (control group)
Number of subjects: 48
Study 19841760 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri‐S Bond (Kuraray)
Number of subjects: 0
Study 19841760 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐Bond (GC)
Number of subjects: 0
Study 19841760 — intervention group
Group type: COMPARATOR
Intervention: Control group (water storage for 24 h)
Number of subjects: 0
Study 17376791 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir 300 mg once daily
Number of subjects: 0
Study 14983571 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning (n = 10)
Number of subjects: 22
Study 14983571 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture (n = 12)
Number of subjects: 22
Study 10378549 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic bronchoscopy
Number of subjects: 1500
Study 10378549 — intervention group
Group type: COMPARATOR
Intervention: Empiric anti-PCP therapy
Number of subjects: 1500
Study 8876274 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic catheterisation (SPC)
Number of subjects: 50
Study 8876274 — intervention group
Group type: COMPARATOR
Intervention: Transurethral catheterisation (TUC)
Number of subjects: 50
Study 1498073 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP plus RT (3000 cGy)
Number of subjects: 151
Study 1498073 — intervention group
Group type: COMPARATOR
Intervention: CVPP alone
Number of subjects: 151
Study 6823470 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise with electromyographic biofeedback
Number of subjects: 30
Study 6823470 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise without electromyographic biofeedback
Number of subjects: 30
Study 6823470 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 30
Study 3959798 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gamma-therapy at a dose of 19.5 Gy
Number of subjects: 40
Study 3959798 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gamma-therapy at a dose of 30 Gy
Number of subjects: 40
Study 3959798 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gamma-therapy at a dose of 40 Gy
Number of subjects: 40
Study 3959798 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 40
Study 31734084 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray plus an oral antidepressant
Number of subjects: 0
Study 31734084 — intervention group
Group type: COMPARATOR
Intervention: New oral antidepressant
Number of subjects: 0
Study 28991048 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 300 mg group (100 mg initial bolus followed by continuous infusion of 300 mg daily for 5 days)
Number of subjects: 99
Study 28991048 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone 200 mg group (50 mg intravenous bolus every 6 h during 7 days)
Number of subjects: 99
Study 28991048 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders (CST response of 9 μg/dL or less)
Number of subjects: 99
Study 28991048 — intervention group
Group type: COMPARATOR
Intervention: Baseline blood cortisol
Number of subjects: 99
Study 27787476 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 12 Hz
Number of subjects: 13
Study 27787476 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 26 Hz
Number of subjects: 13
Study 27787476 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion at 40°
Number of subjects: 13
Study 27787476 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased vibration frequency
Number of subjects: 13
Study 25223164 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gauze soaked with 20 ml of 2% lidocaine
Number of subjects: 24
Study 25223164 — intervention group
Group type: COMPARATOR
Intervention: Chewing gauze soaked with saline
Number of subjects: 24
Study 22812440 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 57
Study 22812440 — intervention group
Group type: COMPARATOR
Intervention: Control (no chewing gum)
Number of subjects: 57
Study 20685723 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced secondary prevention (additional advice, motivational interviewing and telephone support)
Number of subjects: 52
Study 20685723 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 52
Study 18213382 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVVY (1.0% C31G)
Number of subjects: 2153
Study 18213382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2153
Study 18213382 — intervention group
Group type: COMPARATOR
Intervention: SAVVY vs Placebo
Number of subjects: 2153
Study 18213382 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVVY
Number of subjects: 2153
Study 15991068 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 60
Study 15991068 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 60
Study 15991068 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 12672732 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 299
Study 12672732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 10023125 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human nerve growth factor (rhNGF) administered at doses of 0.1 or 0.3 microg/kg subcutaneously 3 days a week for 6 months.
Number of subjects: 209
Study 10023125 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human nerve growth factor (rhNGF) administered at doses up to 1.0 microg/kg intravenously or subcutaneously for up to 12 doses in phase I studies.
Number of subjects: 209
Study 8678284 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (bolus 30 micrograms)
Number of subjects: 40
Study 8678284 — intervention group
Group type: COMPARATOR
Intervention: Piritramide (bolus 1.5 mg)
Number of subjects: 40
Study 1987875 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-tank lithotriptor (group A)
Number of subjects: 711
Study 1987875 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-cushion lithotriptor at low energy levels (group B)
Number of subjects: 711